Baclofen Impact on Gastroesophageal Reflux Disease Symptoms Management

This clinical trial is exploring how adding the drug baclofen to the usual treatment might help people with symptoms of Gastroesophageal Reflux Disease (GERD). GERD is a condition where stomach acid frequently flows back into the tube connecting the mouth and stomach, causing discomfort and other symptoms. The study is important because it seeks to determine whether baclofen can provide additional relief from these symptoms and improve the quality of life for those affected. It also aims to ensure that using baclofen is safe by keeping track of any side effects experienced by participants. Participants in the study will either receive baclofen or a placebo, in addition to their regular treatment, for a period of four weeks. They will take 10 milligrams of baclofen or the placebo three times a day. At the end of the study period, participants will visit the hospital for an assessment. Their GERD symptoms will be evaluated using a specific questionnaire both at the start and after four weeks to see if there is any improvement. Additionally, any side effects reported by participants will be recorded to assess the safety of baclofen.